Does RANIBIZUMAB Cause Vitreous detachment? 82 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Vitreous detachment have been filed in association with RANIBIZUMAB (CIMERLI). This represents 0.5% of all adverse event reports for RANIBIZUMAB.
82
Reports of Vitreous detachment with RANIBIZUMAB
0.5%
of all RANIBIZUMAB reports
3
Deaths
10
Hospitalizations
How Dangerous Is Vitreous detachment From RANIBIZUMAB?
Of the 82 reports, 3 (3.7%) resulted in death, 10 (12.2%) required hospitalization, and 2 (2.4%) were considered life-threatening.
Is Vitreous detachment Listed in the Official Label?
Yes, Vitreous detachment is listed as a known adverse reaction in the official FDA drug label for RANIBIZUMAB.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Vitreous detachment?
PENTOSAN POLYSULFATE (100)
AFLIBERCEPT (63)
BEVACIZUMAB (62)
PILOCARPINE (52)
ADALIMUMAB (45)
CIPROFLOXACIN (36)
INFLIXIMAB (32)
LETROZOLE (27)
METHOTREXATE (26)
ATORVASTATIN (25)
Which RANIBIZUMAB Alternatives Have Lower Vitreous detachment Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE